| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |